Procaterol Hydrochloride

盐酸丙卡特罗

Report date: 2022/05/16 12:12:45
NME

Base Information

Drug NameProcaterol Hydrochloride
Drug Alias Nameprocaterolum盐酸普鲁卡特罗盐酸内卡特罗procaterol丙卡特罗 +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Approved Indications in ChinaPulmonary Disease, Chronic ObstructiveAsthma
Original Approved Country/TerritoryJapan
Original Approved Date1980/10/25
Country/TerritoryIndonesiaMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOtsuka Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOtsuka Pharmaceutical Co LtdZhejiang Otsuka Pharmaceutical Co Ltd
Inactive CompaniesPt Otsuka Indonesia
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeR03AC16R03CC08
Related LinksWikipediaDrugBankKEGG